Opportunity Information: Apply for PA 16 163
Apply for PA 16 163
- The HHS-NIH11 in the health sector is offering a public funding opportunity titled "Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855, 93.856,.
- This funding opportunity was created on Apr 04, 2016 and posted on Apr 04, 2016.
- Applicants must submit their applications by May 07, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $100,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) is a U.S. National Institutes of Health (NIH) funding opportunity designed to support small, collaborative vaccine-focused research projects carried out through partnerships between U.S. and Indian investigators or institutions. Its overarching purpose is to advance vaccine-related science that can help reduce the burden of infectious diseases that matter in India and the United States, with broader relevance to South Asia and global public health. The program emphasizes practical, research-driven collaboration, meaning the work should be structured in a way that clearly benefits from the strengths, resources, populations, or scientific capabilities available across both countries.
This opportunity uses the NIH R03 mechanism, which is commonly used for smaller, early-stage, or targeted projects that can be completed with modest budgets. The award ceiling listed for this announcement is $100,000, indicating that proposed projects should be tightly scoped, focused on achievable aims, and able to generate useful findings, preliminary data, or proof-of-concept results. While the summary description is brief, it makes clear that vaccine-related research is broadly defined and may include work across a variety of infectious diseases, with immunologic characterization specifically highlighted as an example area of interest. In practice, that can include studies that help explain immune responses to vaccines, identify immune correlates of protection, evaluate immunogenicity, or refine vaccine strategies based on immune profiling and related laboratory analyses.
The funding opportunity is classified as discretionary and uses a grant funding instrument, with a health-focused funding activity category. It is associated with CFDA numbers 93.855 and 93.856, which correspond to NIH research and development assistance programs. The administering agency is HHS-NIH (listed as HHS-NIH11 in the source data), reinforcing that applications would follow NIH norms around peer review, project narratives, and compliance expectations typical of NIH grant submissions.
Eligibility is broad and includes many types of U.S. applicant organizations, such as state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (as long as they are not institutions of higher education in the specific category listed); for-profit organizations (other than small businesses); small businesses; and additional applicants as allowed under the program’s eligibility clarifications. In practical terms, the wide eligibility range is meant to accommodate the kinds of entities that might lead or coordinate binational vaccine research collaborations, including universities, research institutes, nonprofits, and certain private-sector groups, depending on project needs.
Key logistical details from the announcement show it was originally created and posted on April 4, 2016, with a listed closing date of May 7, 2019 (both original and current closing dates match in the provided data). The announcement lists “ExpectedAwards:” but does not provide a number in the source text shared, so the anticipated volume of awards is not specified here. The funding opportunity number is PA 16 163, which is the identifier applicants would use to locate the full announcement and application instructions in NIH systems and related federal listings.
Overall, the VAP Small Research Grant Program (R03) is geared toward enabling focused Indo-U.S. collaborative vaccine research projects with clear public health relevance, especially those that can contribute to reducing infectious disease impact through improved understanding of vaccine-related immunology and other supporting vaccine science.
FAQs: Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)
What is the Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)?
It is an NIH funding opportunity that supports small, collaborative, vaccine-focused research projects conducted through partnerships between U.S. and Indian investigators or institutions.
What is the main goal of this grant program?
The purpose is to advance vaccine-related science that can help reduce the burden of infectious diseases important to India and the United States, with broader relevance to South Asia and global public health.
What kinds of projects are a good fit for this opportunity?
The opportunity is designed for tightly scoped, achievable vaccine-focused research projects that benefit from a practical collaboration between U.S. and Indian partners. Projects should be structured so the work clearly gains from strengths, resources, populations, or scientific capabilities available across both countries.
Does the program require a collaboration between U.S. and Indian partners?
Yes. The description emphasizes projects carried out through partnerships between U.S. and Indian investigators or institutions, and it highlights that the research should clearly benefit from cross-country collaboration.
What NIH funding mechanism does this program use?
This opportunity uses the NIH R03 mechanism, which is commonly used for small, early-stage, or targeted research projects that can be completed with modest budgets.
What is the maximum award amount for this funding opportunity?
The award ceiling listed is $100,000, indicating that proposed projects should be focused and sized appropriately for a small grant.
What research areas does the program highlight?
Vaccine-related research is broadly defined. The description specifically highlights immunologic characterization as an example area of interest, such as work to explain immune responses to vaccines, identify immune correlates of protection, evaluate immunogenicity, or refine vaccine strategies using immune profiling and related laboratory analyses.
Is the program limited to a specific infectious disease?
The summary indicates vaccine-related research may include work across a variety of infectious diseases, particularly those that matter in India and the United States.
What types of results are expected from an R03 project under this program?
Because this is a small grant with a defined award ceiling, the program is geared toward projects that can generate useful findings, preliminary data, or proof-of-concept results.
Which agency administers this grant opportunity?
The administering agency is HHS-NIH (listed as HHS-NIH11), meaning applications would follow NIH norms such as peer review and standard NIH compliance expectations.
What is the funding activity category?
The funding activity category is health-focused.
What type of funding instrument is used?
It is a discretionary funding opportunity using a grant funding instrument.
What CFDA numbers are associated with this opportunity?
The announcement is associated with CFDA numbers 93.855 and 93.856, which correspond to NIH research and development assistance programs.
Who is eligible to apply (U.S. side)?
Eligibility is broad and includes many types of U.S. organizations, including: state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (with the noted category limitation in the description); for-profit organizations (other than small businesses); small businesses; and additional applicants as allowed under the program's eligibility clarifications.
Why is eligibility so broad?
The wide eligibility range is intended to accommodate different kinds of organizations that might lead or coordinate binational vaccine research collaborations, including universities, research institutes, nonprofits, and certain private-sector groups depending on project needs.
When was this opportunity posted?
It was originally created and posted on April 4, 2016.
What is the closing date listed in the provided information?
The listed closing date is May 7, 2019 (the original and current closing dates match in the provided data).
Is the expected number of awards provided?
No. The announcement lists "ExpectedAwards:" but does not provide a number in the information shared, so the anticipated volume of awards is not specified here.
What is the funding opportunity number for this announcement?
The funding opportunity number is PA 16 163. This identifier is used to locate the full announcement and application instructions in NIH systems and related federal listings.
What makes an application aligned with the program's emphasis?
Based on the description, alignment comes from proposing a practical, research-driven Indo-U.S. collaboration with clear public health relevance, focused aims that fit a small R03 budget ceiling, and vaccine-related science (including, as an example, immunologic characterization) that can contribute to reducing infectious disease impact.
Browse more opportunities from the same category: Health
Next opportunity: Experimental Program to Stimulate Competitive Research (EPSCoR) Building EPSCoR-State/National Laboratory Partnerships: Sustainable Ammonia Synthesis
Previous opportunity: BLM Utah Arid Land/Rehabilitation of Soils Study
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 16 163
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 16 163) also looked into and applied for these:
| Funding Opportunity |
|---|
| Emerging Infections Programs Apply for CDC RFA CK17 1701 Funding Number: CDC RFA CK17 1701 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| CDC’s Collaboration with Academia to Strengthen Public Health Workforce Capacity Apply for CDC RFA OE12 120105CONT16 Funding Number: CDC RFA OE12 120105CONT16 Agency: HHS-CDC-CSELS Category: Health Funding Amount: Case Dependent |
| Establishment of Resource Centers for Dental, Oral and Craniofacial Tissue Regeneration Consortium (U24) Apply for RFA DE 17 001 Funding Number: RFA DE 17 001 Agency: HHS-NIH11 Category: Health Funding Amount: $2,500,000 |
| American Indians into Nursing Apply for HHS 2016 IHS NU 0001 Funding Number: HHS 2016 IHS NU 0001 Agency: HHS-IHS Category: Health Funding Amount: $400,000 |
| PPHF 2016: Prevention Health and Health Services Block Grants – Behavioral Risk Factor Surveillance System, (BRFSS) – Financed in part by 2016 Prevention and Public Health Funds Apply for CDC RFA DP15 151302CONTPPHF16 Funding Number: CDC RFA DP15 151302CONTPPHF16 Agency: HHS-CDC-NCCDPHP Category: Health Funding Amount: Case Dependent |
| Training and Technical Assistance for Health Department Demonstration Projects for Comprehensive Prevention, Care, Behavioral Health, and Social Services for Men Who Have Sex with Men of Color At Risk for and Living with HIV Infection Apply for CDC RFA PS15 151002CONT16 Funding Number: CDC RFA PS15 151002CONT16 Agency: HHS-CDC-NCHHSTP Category: Health Funding Amount: Case Dependent |
| “Extension of the World Trade Center Health Registry (50)” Apply for RFA OH 16 001 Funding Number: RFA OH 16 001 Agency: HHS-CDC-HHSCDCERA Category: Health Funding Amount: Case Dependent |
| Strengthening sustainable public health capacity in the Eastern Mediterranean Region for polio eradication and routine immunization activities Apply for CDC RFA GH16 160102CONT16 Funding Number: CDC RFA GH16 160102CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Building Public Health Capacity for Drought Response Apply for CDC RFA EH16 1603 Funding Number: CDC RFA EH16 1603 Agency: HHS-CDC-NCEH Category: Health Funding Amount: $150,000 |
| NEI Research Grant for Vision Related Secondary Data Analysis (R21) Apply for PAR 16 168 Funding Number: PAR 16 168 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Educating State-level Stakeholders on Strategies to Address Winnable Battles in Public Health Apply for CDC RFA SO15 150102CONT16 Funding Number: CDC RFA SO15 150102CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Identification of Small Molecules for Sustained-Release Anti-HIV Products (R01) Apply for RFA AI 16 024 Funding Number: RFA AI 16 024 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Advancing HIV Therapeutic Vaccine Science (U01) Apply for RFA AI 16 019 Funding Number: RFA AI 16 019 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Human Tissue Models for Infectious Diseases (U19) Apply for RFA AI 16 022 Funding Number: RFA AI 16 022 Agency: HHS-NIH11 Category: Health Funding Amount: $1,000,000 |
| Noise-Induced Cochlear Synaptopathy: Basic Studies Informing Potential Therapies (R01) Apply for PAR 16 170 Funding Number: PAR 16 170 Agency: HHS-NIH11 Category: Health Funding Amount: $500,000 |
| Innovation for HIV Vaccine Discovery (R01) Apply for PAR 16 171 Funding Number: PAR 16 171 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Limited Competition: IDeA (Institutional Development Award) Core Optimization (Admin Supp) Apply for PA 16 172 Funding Number: PA 16 172 Agency: HHS-NIH11 Category: Health Funding Amount: $350,000 |
| Research Partnerships for Scaling Up Mental Health Interventions in Low-and Middle-Income Countries (U19) Apply for PAR 16 174 Funding Number: PAR 16 174 Agency: HHS-NIH11 Category: Health Funding Amount: $500,000 |
| Affordable Care Act Program for Early Detection of Certain Medical Conditions Related to Environmental Health Hazards Apply for CDC RFA TS15 150102CONT16 Funding Number: CDC RFA TS15 150102CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Resiliency in Communities After Stress and Trauma (Short Title: ReCAST Program) Apply for SM 16 012 Funding Number: SM 16 012 Agency: HHS-SAMHS Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 16 163", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.